Myo-inositol pregravidal training use prospects in women with polycystic ovary syndrome and insulin resistance
Polycystic Ovarian Syndrome (PCOS) is the main infertility cause due to metabolic and hormonal dysfunctions of the ovaries. This syndrome is comorbid with insulin resistance and substantially increases the risk of endometrial hyperplasia, obesity, breast cancer, myocardial infarction and stroke. Wom...
Main Authors: | O A Gromova, E A Goncharova, I Yu Torshin, O A Limanova, N V Kerimkulova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Berlin A.V.
2014-02-01
|
Series: | Гинекология |
Subjects: | |
Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/28298/pdf |
Similar Items
-
Results of treatment with myo-Inositol and D-chiro inositol combination in ratio 5:1 in women with polycystic ovary syndrome
by: Tatiana A. Oboskalova, et al.
Published: (2020-12-01) -
Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols
by: Maria A. Sortino, et al.
Published: (2017-06-01) -
Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies
by: Philippe Merviel, et al.
Published: (2021-01-01) -
A comparative study of combination of Myo-inositol and D-chiro-inositol versus Metformin in the management of polycystic ovary syndrome in obese women with infertility
by: Sujana Thalamati
Published: (2020-12-01) -
Efficiency of the D-chiro-inositol for the polycystic ovary syndrome
by: Т. Л. Архипкина, et al.
Published: (2019-04-01)